Northwestern Mutual Investment Management Company’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.03M Buy
47,655
+202
+0.4% +$11K 0.02% 344
2026
Q1
$2.98M Buy
47,453
+87
+0.2% +$6.96K 0.05% 167
2025
Q4
$4.52M Buy
47,366
+140
+0.3% +$13.7K 0.05% 99
2025
Q3
$4.61M Buy
47,226
+30
+0.1% +$3.11K 0.07% 90
2025
Q2
$5.07M Buy
47,196
+321
+0.7% +$32.5K 0.08% 71
2025
Q1
$4.73M Buy
46,875
+79
+0.2% +$7.96K 0.08% 68
2024
Q4
$4.18M Buy
46,796
+122
+0.3% +$10.7K 0.09% 87
2024
Q3
$3.91M Sell
46,674
-113
-0.2% -$8.91K 0.09% 87
2024
Q2
$3.6M Buy
46,787
+300
+0.6% +$22K 0.09% 94
2024
Q1
$3.18M Buy
46,487
+141
+0.3% +$9.07K 0.08% 117
2023
Q4
$2.68M Buy
46,346
+129
+0.3% +$6.89K 0.07% 132
2023
Q3
$2.44M Buy
46,217
+867
+2% +$45.5K 0.07% 126
2023
Q2
$2.45M Buy
45,350
+327
+0.7% +$17.1K 0.06% 126
2023
Q1
$2.25M Buy
45,023
+131
+0.3% +$6.17K 0.06% 133
2022
Q4
$2.08M Sell
44,892
-8,281
-16% -$359K 0.05% 115
2022
Q3
$2.06M Sell
53,173
-3,962
-7% -$159K 0.05% 127
2022
Q2
$2.13M Buy
57,135
+451
+0.8% +$18.4K 0.05% 148
2022
Q1
$2.51M Sell
56,684
-7,423
-12% -$322K 0.06% 156
2021
Q4
$2.72M Sell
64,107
-562
-0.9% -$23.6K 0.05% 164
2021
Q3
$2.81M Buy
64,669
+141
+0.2% +$6.24K 0.06% 150
2021
Q2
$2.76M Buy
64,528
+282
+0.4% +$11.9K 0.05% 148
2021
Q1
$2.48M Sell
64,246
-14,336
-18% -$543K 0.04% 151
2020
Q4
$2.83M Buy
78,582
+97
+0.1% +$3.5K 0.04% 205
2020
Q3
$2.76M Hold
78,485
0.04% 178
2020
Q2
$2.76M Buy
78,485
+5,839
+8% +$210K 0.04% 175
2020
Q1
$2.37M Buy
72,646
+18,502
+34% +$723K 0.04% 168
2019
Q4
$2.45M Buy
54,144
+1,098
+2% +$45.9K 0.04% 167
2019
Q3
$2.16M Buy
53,046
+298
+0.6% +$12.6K 0.05% 180
2019
Q2
$2.27M Sell
52,748
-157,857
-75% -$6.07M 0.05% 168
2019
Q1
$8.08M Buy
210,605
+2,093
+1% +$79.9K 0.15% 126
2018
Q4
$7.37M Sell
208,512
-33,487
-14% -$1.21M 0.12% 126
2018
Q3
$9.32M Sell
241,999
-22,228
-8% -$776K 0.14% 138
2018
Q2
$8.64M Buy
264,227
+13,961
+6% +$421K 0.13% 148
2018
Q1
$6.84M Sell
250,266
-59,904
-19% -$1.63M 0.11% 169
2017
Q4
$7.69M Buy
310,170
+2,539
+0.8% +$70K 0.13% 169
2017
Q3
$8.97M Sell
307,631
-6,611
-2% -$183K 0.15% 135
2017
Q2
$8.71M Buy
314,242
+38,623
+14% +$1.03M 0.15% 133
2017
Q1
$6.86M Buy
275,619
+119,260
+76% +$2.9M 0.12% 147
2016
Q4
$3.38M Buy
156,359
+21,737
+16% +$474K 0.07% 176
2016
Q3
$3.2M Buy
134,622
+82,856
+160% +$1.98M 0.07% 161
2016
Q2
$1.21M Buy
51,766
+283
+0.5% +$6.12K 0.03% 235
2016
Q1
$968K Sell
51,483
-11,965
-19% -$210K 0.02% 300
2015
Q4
$1.17M Buy
63,448
+1,524
+2% +$27.3K 0.02% 330
2015
Q3
$1.02M Buy
61,924
+404
+0.7% +$6.91K 0.02% 365
2015
Q2
$1.09M Sell
61,520
-854
-1% -$15.3K 0.02% 377
2015
Q1
$1.11M Buy
+62,374
New +$986K 0.02% 389

Other funds holding BSX

Northwestern Mutual Investment Management Company's BSX Position: Q2 2026 in Review

Northwestern Mutual Investment Management Company increased its Boston Scientific (BSX) stake by 0.43% in Q2 2026, buying an estimated $11K and bringing the position to 47,655 shares worth $2.03M. The position accounts for 0.02% of the portfolio, ranked #344.

Northwestern Mutual Investment Management Company first reported a position in BSX in Q1 2015 and has held it in 46 quarters since. The position peaked at $9.32M in Q3 2018. 1,050 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Northwestern Mutual Investment Management Company held 47,655 shares of Boston Scientific worth $2.03M as of Q2 2026.
  • Northwestern Mutual Investment Management Company bought 202 Boston Scientific shares in Q2 2026, an estimated $11K.
  • Boston Scientific made up 0.02% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #344 holding.
  • Northwestern Mutual Investment Management Company first reported a position in Boston Scientific in Q1 2015 and has held it in 46 quarters since.
  • Northwestern Mutual Investment Management Company's Boston Scientific position peaked at $9.32M in Q3 2018.
  • 1,050 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.